Background Men using cholesterol-lowering statin medications have been found to have
lower risks of both advanced and fatal prostate cancer in multiple registry-based studies and …

Background. With the growth and aging of population, the incidence of prostate cancer will
increase year by year, which is bound to bring greater economic burden to the society …

Background. The use of statins is a potential protective factor against the development of
hepatocellular carcinoma. Therefore, we conducted a meta‐analysis to evaluate the …

Purpose Statins' cholesterol-lowering efficacy is well-known. Recent epidemiological studies
have found that inhibition of cholesterol synthesis may have beneficial effects on prostate …

We evaluated the association between aspirin, statins, and metformin use and prostate
cancer (PC) incidence and mortality using a large population-based dataset. 388,760 men …

Background Conflicting evidence suggests that statins act chemopreventively against
prostate cancer (PCa). Whether the association of statin use with PCa risk is Gleason score …

Multidrug resistance mediated by ATP‐binding cassette (ABC) transporters remains a major
impediment to cancer chemotherapy. In the present study, we documented that doxorubicin …

Background: Whether statins can reduce the incidence of cancers has been an interesting
topic in recent years. This meta-analysis aimed to determine the relationship between statin …

Background: A link between statin use and prostate cancer risk has been proposed.
Epidemiologic evidence is, however, inconclusive, and data for specific statin types as well …

Background: There is a growing body of evidence supporting the protective effect of statins
on the risk of prostate cancer, in particular aggressive disease. Past research has mostly …